“Efficacy of Oral DFD-29, a Low-Dose Minocycline Formulation, in Patients With Rosacea: A Pooled Analysis of Two Phase 3 Trials” (2025) SKIN The Journal of Cutaneous Medicine, 9(6), p. s696. doi:10.25251/p39dms53.